Plasmid DNA Contract Manufacturing Market Size, Share & Trends Report

Plasmid DNA Contract Manufacturing Market Size, Share & Trends Analysis Report By Application, By Therapeutic Area, By End-user, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453166
  • Number of Pages: 0
  • Format: Electronic (PDF)

Table of Content

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                         1.1.1. Application
                         1.1.2. Therapeutic Area
                         1.1.3. End-user
                         1.1.4. Regional scope
                         1.1.5. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                         1.3.1. Purchased database
                         1.3.2. GVR’s internal database
                         1.3.3. Secondary sources
                         1.3.4. Primary research
                         1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                         1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                         1.6.1. Commodity flow analysis (Model 1)
                             1.6.1.1. Approach 1: Commodity flow approach
                         1.6.2. Volume price analysis (Model 2)
                             1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
                         1.9.1. Objective 1
                         1.9.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
Chapter 3. Plasmid DNA Contract Manufacturing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                         3.1.1. Parent market outlook
                         3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Industry Value Chain Analysis
                         3.3.1. Reimbursement framework
                    3.4. Market Dynamics
                         3.4.1. Market driver analysis
                             3.4.1.1. Increasing disease prevalence
                             3.4.1.2. Growing Investments in Research Studies
                             3.4.1.3. Growing Popularity of Gene Therapy
                         3.4.2. Market restraint analysis
                             3.4.2.1. Lack of advanced infrastructure for manufacturing in certain developing countries
                             3.4.2.2. Quality Issues associated with Contract Manufacturing
                    3.5. Plasmid DNA Contract Manufacturing Market Analysis Tools
                         3.5.1. Industry Analysis – Porter’s
                         3.5.2. PESTEL Analysis
                         3.5.3. Major Deals & Strategic Alliances Analysis
                         3.5.4. Covid Impact Analysis
Chapter 4. Plasmid DNA Contract Manufacturing Market: Application Estimates & Trend Analysis
                    4.1. Definitions and Scope
                    4.2. Plasmid DNA Contract Manufacturing Market Share, 2021 & 2030
                    4.3. Segment Dashboard
                    4.4. Global Plasmid DNA Contract Manufacturing Market by Application Outlook
                    4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                         4.5.1. Gene Therapy
                             4.5.1.1. Gene Therapy market estimates and forecast 2018 to 2030, (USD Million)
                         4.5.2. Immunotherapy
                             4.5.2.1. Immunotherapy Market estimates and forecast 2018 to 2030, (USD Million)
                         4.5.3. Others
                             4.5.3.1. Others Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 5. Plasmid DNA Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis
                    5.1. Definitions and Scope
                    5.2. Plasmid DNA Contract Manufacturing Market Share, 2021 & 2030
                    5.3. Segment Dashboard
                    5.4. Global Plasmid DNA Contract Manufacturing Market by Therapeutic Area Outlook
                    5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                         5.5.1. Cancer
                             5.5.1.1. Cancer market estimates and forecast 2018 to 2030, (USD Million)
                         5.5.2. Infectious Diseases
                             5.5.2.1. Infectious Diseases Market estimates and forecast 2018 to 2030, (USD Million)
                         5.5.3. Autoimmune Diseases
                             5.5.3.1. Autoimmune Diseases Market estimates and forecast 2018 to 2030, (USD Million)
                         5.5.4. Cardiovascular Diseases
                             5.5.4.1. Cardiovascular Diseases Market estimates and forecast 2018 to 2030, (USD Million)
                         5.5.5. Others
                             5.5.5.1. Others Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 6. Plasmid DNA Contract Manufacturing Market: End User Estimates & Trend Analysis
                    6.1. Definitions and Scope
                    6.2. Plasmid DNA Contract Manufacturing Market Share, 2021 & 2030
                    6.3. Segment Dashboard
                    6.4. Global Plasmid DNA Contract Manufacturing Market by End User Outlook
                    6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                         6.5.1. Pharmaceutical and Biotechnology Companies
                             6.5.1.1. Pharmaceutical and Biotechnology Companies market estimates and forecast 2018 to 2030, (USD Million)
                         6.5.2. Research Institutes
                             6.5.2.1. Research Institutes Market estimates and forecast 2018 to 2030, (USD Million)
Chapter 7. Plasmid DNA Contract Manufacturing Market: Regional Estimates & Trend Analysis
                    7.1. Regional market share analysis, 2021 & 2030
                    7.2. Regional Market Dashboard
                    7.3. Global Regional Market Snapshot
                    7.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
                    7.5. North America
                         7.5.1. Market estimates and forecast, 2018-2030
                         7.5.2. U.S.
                             7.5.2.1. U.S. Market estimates and forecast, 2018-2030
                         7.5.3. Canada
                             7.5.3.1. Canada Market estimates and forecast, 2018-2030
                    7.6. Europe
                         7.6.1. UK
                             7.6.1.1. UK Market estimates and forecast, 2018-2030
                         7.6.2. Germany
                             7.6.2.1. Germany Market estimates and forecast, 2018-2030
                         7.6.3. France
                             7.6.3.1. France Market estimates and forecast, 2018-2030
                         7.6.4. Italy
                             7.6.4.1. Italy Market estimates and forecast, 2018-2030
                         7.6.5. Spain
                             7.6.5.1. Spain Market estimates and forecast, 2018-2030
                         7.6.6. Russia
                             7.6.6.1. Russia Market estimates and forecast, 2018-2030
                         7.6.7. Turkey
                             7.6.7.1. Turkey Market estimates and forecast, 2018-2030
                         7.6.8. Netherlands
                             7.6.8.1. Netherlands Market estimates and forecast, 2018-2030
                         7.6.9. Switzerland
                             7.6.9.1. Switzerland Market estimates and forecast, 2018-2030
                         7.6.10. Sweden
                             7.6.10.1. Sweden Market estimates and forecast, 2018-2030
                    7.7. Asia Pacific
                         7.7.1. Japan
                             7.7.1.1. Japan Market estimates and forecast, 2018-2030
                         7.7.2. China
                             7.7.2.1. China Market estimates and forecast, 2018-2030
                         7.7.3. India
                             7.7.3.1. India Market estimates and forecast, 2018-2030
                         7.7.4. Thailand
                             7.7.4.1. Thailand Market estimates and forecast, 2018-2030
                         7.7.5. South Korea
                             7.7.5.1. South Korea Market estimates and forecast, 2018-2030
                         7.7.6. Indonesia
                             7.7.6.1. Indonesia Market estimates and forecast, 2018-2030 \
                         7.7.7. Malaysia
                             7.7.7.1. Malaysia Market estimates and forecast, 2018-2030
                         7.7.8. Singapore
                             7.7.8.1. Singapore Market estimates and forecast, 2018-2030
                         7.7.9. Thailand
                             7.7.9.1. Thailand Market estimates and forecast, 2018-2030
                         7.7.10. Taiwan
                             7.7.10.1. Taiwan Market estimates and forecast, 2018-2030
                    7.8. Latin America
                         7.8.1. Brazil
                             7.8.1.1. Brazil Market estimates and forecast, 2018-2030
                         7.8.2. Mexico
                             7.8.2.1. Mexico Market estimates and forecast, 2018-2030
                         7.8.3. Argentina
                             7.8.3.1. Argentina Market estimates and forecast, 2018-2030
                         7.8.4. Colombia
                             7.8.4.1. Colombia Market estimates and forecast, 2018-2030
                         7.8.5. Chile
                             7.8.5.1. Chile Market estimates and forecast, 2018-2030
                    7.9. MEA
                         7.9.1. South Africa
                             7.9.1.1. South Africa Market estimates and forecast, 2018-2030
                         7.9.2. Saudi Arabia
                             7.9.2.1. Saudi Arabia Market estimates and forecast, 2018-2030
                         7.9.3. UAE
                             7.9.3.1. UAE Market estimates and forecast, 2018-2030
                         7.9.4. Egypt
                             7.9.4.1. Egypt Market estimates and forecast, 2018-2030
                         7.9.5. Israel                         
                             7.9.5.1. Israel Market estimates and forecast, 2018-2030
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                         8.2.1. Innovators
                    8.3. Vendor Landscape
                         8.3.1. List of key distributors and channel partners
                         8.3.2. Key customers
                         8.3.3. Key company market share analysis, 2018
                         8.3.4. Charles River Laboratories
                             8.3.4.1. Company overview
                             8.3.4.2. Product benchmarking
                             8.3.4.3. Strategic initiatives
                         8.3.5. VGXI, Inc.
                             8.3.5.1. Company overview
                             8.3.5.2. Financial performance
                             8.3.5.3. Product benchmarking
                             8.3.5.4. Strategic initiatives
                         8.3.6. PlasmidFactory GmbH & Co. KG
                             8.3.6.1. Company overview
                             8.3.6.2. Financial performance
                             8.3.6.3. Product benchmarking
                             8.3.6.4. Strategic initiatives
                         8.3.7. Boehringer Ingelheim
                             8.3.7.1. Company overview
                             8.3.7.2. Financial performance
                             8.3.7.3. Product benchmarking
                             8.3.7.4. Strategic initiatives
                         8.3.8. BioCina
                             8.3.8.1. Company overview
                             8.3.8.2. Financial performance
                             8.3.8.3. Product benchmarking
                             8.3.8.4. Strategic initiatives
                         8.3.9. Aldevron
                             8.3.9.1. Company overview
                             8.3.9.2. Financial performance
                             8.3.9.3. Product benchmarking
                             8.3.9.4. Strategic initiatives
                         8.3.10. TriLink BioTechnologies
                             8.3.10.1. Company overview
                             8.3.10.2. Financial performance
                             8.3.10.3. Product benchmarking
                             8.3.10.4. Strategic initiatives
                         8.3.11. Esco Aster Pte. Ltd
                             8.3.11.1. Company overview
                             8.3.11.2. Financial performance
                             8.3.11.3. Product benchmarking
                             8.3.11.4. Strategic initiatives

 



What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.